News Releases

NEW YORK and TORONTO and HERZLIYA, Israel, Oct. 13, 2021 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that Alexander Rabinovitch, CEO of InterCure, will present at the Benzinga Cannabis Capital Conference

NEW YORK, TORONTO and HERZLIYA, Israel, Oct. 12, 2021 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the “Company”) today announced that CEO Alexander Rabinovitch purchased, throughout the month of September 2021, a total of 423,501

Achieved record revenue of NIS 45 million (over CAD$17 million), an increase of 400% year-over-year and 37% quarter-over-quarter Achieved quarterly run-rate Q2 Pro Forma 1 revenues of NIS 55 million (over CAD$21 million) Recorded continued increase in operating profit, EBITDA 2 and net profit

Acquisition includes two medical cannabis dispensing pharmaci es , another pharmacy in the process of receiving its license and a medical cannabis patient support center C ompanies will partner in Cannomed online platform dedicated to fulfilling orders of medical cannabis products and in medical

The leading cannabis company outside North America debuts today on Nasdaq NEW YORK and TORONTO and HERZLIYA, Israel, Sept. 01, 2021 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) (the “Company”) is pleased to announce the Company’s common shares will

InterCure Ltd. (TSX: INCR.U) (TASE: INCR) (dba Canndoc) (the "Company") is pleased to announce its financial results for the second quarter of 2021 and provide a business update. All amounts are expressed in New Israeli Shekels (NIS) or Canadian dollars ($), unless otherwise noted.

Trading expected to begin in the last week of July TORONTO, July 19, 2021 (GLOBE NEWSWIRE) -- InterCure Ltd . (TSX: INCR.U, TASE: INCR)(dba Canndoc)(the “ Company ”) is pleased to announce that further to its confidential filing with the U.S. Securities and Exchange Commission (the " SEC ") of its

Trading on the world's leading stock exchange expected to begin in the last week of July TORONTO and HERZLIYA, Israel, July 10, 2021 (GLOBE NEWSWIRE) -- InterCure Ltd . (TSX: INCR.U, TASE: INCR)(dba Canndoc)(the “ Company ”) is pleased to announce that further to its confidential filing with the

Acquisition of one of the  leading   active ,  IMCA approved trade houses in Israel expand ing   InterCure's   sales channel,  d istribution ,   d elivery  and  s torage  capacity . As part of the acquisition, two additional pharmacies added  to  Intercure’ s   leading medical focused, pharmacy

InterCure Announces Another Record-Breaking First Quarter Financial Results Toronto, Canada, and Herzliya, Israel – May 17, 2021 – InterCure Ltd . (TSX: INCR:U, TASE: INCR)(dba Canndoc)("I ntercure " or the the “Company”) today reported financial results for the first quarter of 2021.